Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: NOVAVAX INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-06-04 to 2022-12-03
Current total value of award: $45670659
Description: COVID 19 VACCINE DEVELOPMENT AND PRODUCTION